AIM AIM ImmunoTech

$AIM The collaborators for the new trial are interesting: Dr. Kalinski; Dr Edwards, of UPMC Magee Womens Hospital; Northwest Biotherapeutics $NWBO AIM ImmunoTech Inc. There had been rumors about a collaboration, so it is interesting to see what might come of it.

$AIM Ten years and three reverse splits. Tommy, you have kept the shorts very happy while patients and stockholders have suffered in my opinion. Do you really think you are a hero to patients and stockholders?

$AIM When was the last time that a press release from this company prestented some actual news rather than just repeating stale pumps?

$AIM the criminal shorts are still connected in the hart of the company every time news is on the way they short harder. Trading on such info is illegal. It’s called insider trading.

$AIM AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

$AIM Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer Dr Kalinski and Dr Edwards are starting a new trial. This was mentioned back in June. h/T

$AIM Just food for thought. About a month ago I Grok'd what was a microcap company that might 10x. Besides a bunch of warning caveats it gave one example stock. This one.

$AIM this company spends more time figuring out new ways to scam new investors then it does getting their drug over the finish line with a deal with big Pharma. Pathetic leadership

$AIM bastards, spent another 5 grand .25 now at .18, averaging down for sure. 60g tied up in this now...

$AIM I'm not sure what impact having the company's lawyer/CEO read a press release to a webcam in his den/office will have. But, I suppose that it is kind of entertaining in its own sort of way. It kind of reminded me of what it was like watching Biden trying to read a speech off of a teleprompter near the end of his term.

$AIM AIM leadership has led AIM shareholders to an all-time new low today, 9/25/2026. - Down 99.9% in past 5 years - Down 92.7% in past 1 year The leadership team that has overseen this destruction of value still get compensated and have remained in their roles despite their monumental failures. On 9/22/26, AIM issued a bizarre press release about Revolution Medicine's daraxonrasib, an FDA approved drug. It appears that AIM leadership thinks a comparison between ampligen and daraxonrasib is a wise decision, but daraxonrasib is FDA approved and a Phase 3 with 500 enrollments. (NCT06625320). Completely bizarre.

$AIM Accounting for reverse splits, this stock once closed at $905,819.56 per share. Since then, the share price has fallen 99.9999779% Investors ignore this company's history at their own peril.

$AIM Intellectual Property & Patent Expansions Long COVID Protection: AIM significantly expanded its global patent portfolio, securing patent protection in Europe and the United Kingdom covering Ampligen for Long COVID, extending exclusivity through June 2041. Oncology Combinations: The U.S. Patent and Trademark Office (USPTO) granted a broad patent covering the use of Ampligen in combination with pembrolizumab (Keytruda) for cancer treatment, protecting the IP landscape through 2039.

$AIM you wonder why it spikes up a little.? I scooped up a little bit of shares the croocks trade in between own accounts to get us lower…

$AIM once upon a time I had 1% of the company. If they had taken the bad deal from Roswell I would have been robbed but I would have been rather happy. If the next split comes along I’ll be left with 2000 shares . Not much good can come from that. The hedgies said they would clean us out and after 30+ years they have nearly succeeded

$AIM this ticker could absolutely skyrocket with volume. Happy to be sitting on some shares

$AIM I like this stock. Slow climb then explosive 🧨? Maybe today, maybe next week, but I’m holding a big bag just over .20 right now. Let’s bring er back to life

$AIM at this price it’s ultra easy to buy up potential. Give it some volume, some buyers (which can buy copious amounts), and Boom Shaka Lakka

$AIM Some may believe we have witnessed years of fraud for the benefit of the shorts. Has there been perpetual hyoe but no delivery? Let others decide.